Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Northway Biotech Adds Gene Therapy CDMO Capabilities in Vilnius, Lithuania | Contract Pharma
Breaking News

Northway Biotech Adds Gene Therapy CDMO Capabilities in Vilnius, Lithuania

To offer viral vector and plasmid cGMP manufacturing, cell banking and full characterization, and analytical and quality testing.

Northway Biotech has launched its Gene Therapy Center in Vilnius Lithuania, the first in the Baltic States. This state-of-the-art facility is the first building of the BIO CITY project, where the goal is to build Europe’s largest biotechnology hub and support innovative companies.
 
The 8,000 square meter facility is equipped with the latest technology to offer viral vector and plasmid cGMP manufacturing, cell banking and full characterization, and analytical and quality testing, including viral clearance studies.
 
The BIO CITY project, led by Northway Biotech, is rapidly expanding and will include additional facilities by 2030, enhancing capacity to help clients bring therapies to market.
 
Northway group is one of the Lithuanian biotechnology market leaders. The group’s biotechnology cluster comprises seven companies: five in Lithuania, one in the UK and one in the U.S. In the latter market, Northway is the largest biotechnology investor in the Baltic region. Together, these companies employ more than 200 professionals.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters